| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Section on Pharmacology, Laboratory of Clinical Science, National Institute of Mental Health Bethesda, Maryland 20892
Correspondence: Address requests for reprints to: J. M. Saavedra, M.D., Section on Pharmacology, Laboratory of Clinical Science, National Institute of Mental Health, 9000 Rockville Pike, Building 10, Room 2D-45, Bethesda, Maryland 20892.
Abstract
I. Introduction: Angiotensin(ANG II) was discovered about 50 yr ago (1, 2), and a complete peripheral system for the formation and metabolism of ANG II was soon characterized. It was named the renin-angiotensin system, based on the rate-limiting enzyme, renin, and the active principle, ANG II (3). In the classical peripheral RAS system, a precursor molecule, angiotensinogen (AOGEN), originates in the liver and is cleaved to the essentially inactive decapeptide angiotensin I (ANG I) by an aspartyl protease, renin, synthesized and released to the circulation mainly by the juxtaglomerular cells of the kidney. ANG I is converted to ANG II, the effector peptide of this system, by the angiotensin-converting enzyme (ACE) (4). Circulating ANG II acts on high affinity ANG II receptors located in the vascular smooth muscle, zona glomerulosa of the adrenal gland, and kidney to produce vasoconstriction, aldosterone release, and sodium retention, respectively. Thus, the peripheral RAS is a hormonal system with important functions in the regulation of blood pressure and fluid homeostasis.
This article has been cited by other articles:
![]() |
K. M. Elased, T. S. Cunha, F. K. Marcondes, and M. Morris Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice Exp Physiol, May 1, 2008; 93(5): 665 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bodineau, A. Frugiere, Y. Marc, N. Inguimbert, C. Fassot, F. Balavoine, B. Roques, and C. Llorens-Cortes Orally Active Aminopeptidase A Inhibitors Reduce Blood Pressure: A New Strategy for Treating Hypertension Hypertension, May 1, 2008; 51(5): 1318 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Braszko, A. Walesiuk, and P. Wielgat Cognitive Effects Attributed to Angiotensin II may Result from its Conversion to Angiotensin IV Journal of Renin-Angiotensin-Aldosterone System, September 1, 2006; 7(3): 168 - 174. [Abstract] [PDF] |
||||
![]() |
W. Raasch, C. Wittmershaus, A. Dendorfer, I. Voges, F. Pahlke, C. Dodt, P. Dominiak, and O. Johren Angiotensin II Inhibition Reduces Stress Sensitivity of Hypothalamo-Pituitary-Adrenal Axis in Spontaneously Hypertensive Rats Endocrinology, July 1, 2006; 147(7): 3539 - 3546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou, J. Pavel, M. Macova, Z.-X. Yu, H. Imboden, L. Ge, T. Nishioku, J. Dou, E. Delgiacco, and J. M. Saavedra AT1 Receptor Blockade Regulates the Local Angiotensin II System in Cerebral Microvessels From Spontaneously Hypertensive Rats Stroke, May 1, 2006; 37(5): 1271 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuura, H. Kumagai, H. Onimaru, A. Kawai, K. Iigaya, T. Onami, K. Sakata, N. Oshima, T. Sugaya, and T. Saruta Electrophysiological Properties of Rostral Ventrolateral Medulla Neurons in Angiotensin II 1a Receptor Knockout Mice Hypertension, August 1, 2005; 46(2): 349 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vazquez, M. F. C. de Adjounian, C. Sumners, A. Gonzalez, C. Diez-Freire, and M. K. Raizada Selective Silencing of Angiotensin Receptor Subtype 1a (AT1aR) by RNA Interference Hypertension, January 1, 2005; 45(1): 115 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lochard, G. Thibault, D. W. Silversides, R. M. Touyz, and T. L. Reudelhuber Chronic Production of Angiotensin IV in the Brain Leads to Hypertension That Is Reversible With an Angiotensin II AT1 Receptor Antagonist Circ. Res., June 11, 2004; 94(11): 1451 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Uresin, B. Erbas, M. Ozek, E. Ozkok, and A. O. Gurol Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress Journal of Renin-Angiotensin-Aldosterone System, June 1, 2004; 5(2): 93 - 96. [Abstract] [PDF] |
||||
![]() |
J. ANTUNES-RODRIGUES, M. DE CASTRO, L. L. K. ELIAS, M. M. VALENCA, and S. M. McCANN Neuroendocrine Control of Body Fluid Metabolism Physiol Rev, January 1, 2004; 84(1): 169 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-L. Hoe, I. Armando, G. Baiardi, T. Sreenath, A. Kulkarni, A. Martianez, and J. M. Saavedra Molecular cloning, characterization, and distribution of the gerbil angiotensin II AT2 receptor Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2003; 285(6): R1373 - R1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Son, M. K. Hur, B. J. Ryu, S. K. Park, G. Damante, A. V. D'Elia, M. E. Costa, S. R. Ojeda, and B. J. Lee TTF-1, a Homeodomain-containing Transcription Factor, Participates in the Control of Body Fluid Homeostasis by Regulating Angiotensinogen Gene Transcription in the Rat Subfornical Organ J. Biol. Chem., July 11, 2003; 278(29): 27043 - 27052. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bregonzio, I. Armando, H. Ando, M. Jezova, G. Baiardi, and J. M. Saavedra Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G414 - G423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jezova, I. Armando, C. Bregonzio, Z.-X. Yu, S. Qian, V. J. Ferrans, H. Imboden, and J. M. Saavedra Angiotensin II AT1 and AT2 Receptors Contribute to Maintain Basal Adrenomedullary Norepinephrine Synthesis and Tyrosine Hydroxylase Transcription Endocrinology, May 1, 2003; 144(5): 2092 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Shade, J. R. Blair-West, K. D. Carey, L. J. Madden, R. S. Weisinger, and D. A. Denton Synergy between angiotensin and aldosterone in evoking sodium appetite in baboons Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1070 - R1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, H. Yamakawa, C. Bregonzio, J. A. Terron, A. Falcon-Neri, and J. M. Saavedra Protection Against Ischemia and Improvement of Cerebral Blood Flow in Genetically Hypertensive Rats by Chronic Pretreatment With an Angiotensin II AT1 Antagonist Stroke, September 1, 2002; 33(9): 2297 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, G. Shaw, and M. K. Raizada ANG II stimulation of neuritogenesis involves protein kinase B in brain neurons Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R107 - R114. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-L. Hoe and J. M. Saavedra Site-Directed Mutagenesis of the Gerbil and Human Angiotensin II AT1 Receptors Identifies Amino Acid Residues Attributable to the Binding Affinity for the Nonpeptidic Antagonist Losartan Mol. Pharmacol., June 1, 2002; 61(6): 1404 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kitiyakara, W. J. Welch, J. G. Verbalis, and C. S. Wilcox Role of thromboxane receptors in the dipsogenic response to central angiotensin II Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R865 - R869. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Llorens-Cortes and F. A. Mendelsohn Organisation and functional role of the brain angiotensin system Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1_suppl): S39 - S48. [PDF] |
||||
![]() |
D. A. Scheuer and A. G. Bechtold Glucocorticoids modulate baroreflex control of heart rate in conscious normotensive rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R475 - R483. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mustafa, Joo Hyung Lee, Siew Yeen Chai, A. L Albiston, S. G McDowall, and F. A. Mendelsohn Bioactive angiotensin peptides: focus on angiotensin IV Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 205 - 210. [PDF] |
||||
![]() |
T. Ito, Y. Nishimura, and J. Saavedra Pre-treatment with candesartan protects from cerebral ischaemia Journal of Renin-Angiotensin-Aldosterone System, September 1, 2001; 2(3): 174 - 179. [Abstract] [PDF] |
||||
![]() |
I. Armando, A. Carranza, Y. Nishimura, K.-L. Hoe, M. Barontini, J. A. Terron, A. Falcon-Neri, T. Ito, A. V. Juorio, and J. M. Saavedra Peripheral Administration of an Angiotensin II AT1 Receptor Antagonist Decreases the Hypothalamic-Pituitary-Adrenal Response to Isolation Stress Endocrinology, September 1, 2001; 142(9): 3880 - 3889. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, X. Wang, and M. K. Raizada Characterization of Signal Transduction Pathway in Neurotropic Action of Angiotensin II in Brain Neurons Endocrinology, August 1, 2001; 142(8): 3502 - 3511. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gohlke, S. Weiss, A. Jansen, W. Wienen, J. Stangier, W. Rascher, J. Culman, and T. Unger AT1 Receptor Antagonist Telmisartan Administered Peripherally Inhibits Central Responses to Angiotensin II in Conscious Rats J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 62 - 70. [Abstract] [Full Text] |
||||
![]() |
J. Culman, J. Baulmann, A. Blume, and T. Unger Review: The renin-angiotensin system in the brain: an update Journal of Renin-Angiotensin-Aldosterone System, June 1, 2001; 2(2): 96 - 102. [PDF] |
||||
![]() |
D. A. Scheuer and A. G. Bechtold Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1719 - R1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Moellenhoff, A. Blume, J. Culman, B. Chatterjee, T. Herdegen, C. J. Lebrun, and T. Unger Effect of repetitive icv injections of ANG II on c-Fos and AT1-receptor expression in the rat brain Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1095 - R1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gonzalez Iglesias, C. Suarez, C. Feierstein, G. Diaz-Torga, and D. Becu-Villalobos Desensitization of angiotensin II: effect on [Ca2+]i, inositol triphosphate, and prolactin in pituitary cells Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E462 - E470. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Saavedra, T. Ito, and Y. Nishimura Review: The role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S102 - S109. [PDF] |
||||
![]() |
I. Armando, A. Carranza, Y. Nishimura, M. Barontini, T. Ito, and J. M Saavedra Candesartan decreases the sympatho-adrenal and hormonal response to isolation stress Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S130 - S135. [Abstract] [PDF] |
||||
![]() |
X. Wang, H. Yang, and M. K. Raizada Angiotensin II Increases Vesicular Trafficking in Brain Neurons Hypertension, February 1, 2001; 37(2): 677 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Monti, M. Schinke, M. Bohm, D. Ganten, M. Bader, and G. Bricca Glial angiotensinogen regulates brain angiotensin II receptors in transgenic rats TGR(ASrAOGEN) Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R233 - R240. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. VilaPorcile, A. Barret, and P. Corvol Secretion of Renin-Angiotensin System (RAS) Components by Normal and Tumoral Lactotropes: A Comparative Study Using Reverse Hemolytic Plaque Assay (RHPA) and Immunoelectron Microscopy J. Histochem. Cytochem., December 1, 2000; 48(12): 1691 - 1704. [Abstract] [Full Text] |
||||
![]() |
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishimura, T. Ito, J. M. Saavedra, and K. Sandberg Angiotensin II AT1 Blockade Normalizes Cerebrovascular Autoregulation and Reduces Cerebral Ischemia in Spontaneously Hypertensive Rats Editorial Comment Stroke, October 1, 2000; 31(10): 2478 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. ALBRECHT, T. NITSCHKE, and O. VON BOHLEN UND HALBACH Various effects of angiotensin II on amygdaloid neuronal activity in normotensive control and hypertensive transgenic [TGR(mREN-2)27] rats FASEB J, May 1, 2000; 14(7): 925 - 931. [Abstract] [Full Text] |
||||
![]() |
D. B. Jennings and H. J. Lockett Angiotensin stimulates respiration in spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1125 - R1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Alvarez, V. Alvarez, C. H Lahoz, C. Martinez, J. Pena, J. M Sanchez, L. M Guisasola, J. Salas-Puig, G. Moris, J. A Vidal, et al. Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, December 1, 1999; 67(6): 733 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Reaux, M. C. Fournie-Zaluski, C. David, S. Zini, B. P. Roques, P. Corvol, and C. Llorens-Cortes Aminopeptidase A inhibitors as potential central antihypertensive agents PNAS, November 9, 1999; 96(23): 13415 - 13420. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, M. J. Katovich, C. H. Gelband, P. Y. Reaves, M. I. Phillips, and M. K. Raizada Sustained Inhibition of Angiotensin I-Converting Enzyme (ACE) Expression and Long-Term Antihypertensive Action by Virally Mediated Delivery of ACE Antisense cDNA Circ. Res., October 1, 1999; 85(7): 614 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Wright, L. Stubley, E. S. Pederson, E. A. Kramar, J. M. Hanesworth, and J. W. Harding Contributions of the Brain Angiotensin IV-AT4 Receptor Subtype System to Spatial Learning J. Neurosci., May 15, 1999; 19(10): 3952 - 3961. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang and M. K. Raizada Role of Phosphatidylinositol 3-Kinase in Angiotensin II Regulation of Norepinephrine Neuromodulation in Brain Neurons of the Spontaneously Hypertensive Rat J. Neurosci., April 1, 1999; 19(7): 2413 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lenkei, A. M. Nuyt, D. Grouselle, P. Corvol, and C. Llorens-Cortès Identification of Endocrine Cell Populations Expressing the AT1B Subtype of Angiotensin II Receptors in the Anterior Pituitary Endocrinology, January 1, 1999; 140(1): 472 - 477. [Abstract] [Full Text] |
||||
![]() |
H. Yang and M. K. Raizada MAP Kinase–Independent Signaling in Angiotensin II Regulation of Neuromodulation in SHR Neurons Hypertension, September 1, 1998; 32(3): 473 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Heitman and D. B. Jennings Angiotensin II modulates respiratory and acid-base responses to prolonged hypoxia in conscious dogs Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R390 - R399. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lu, H. Yang, R. H. Lenox, and M. K. Raizada Regulation of Angiotensin II-induced Neuromodulation by MARCKS in Brain Neurons J. Cell Biol., July 13, 1998; 142(1): 217 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. FITZSIMONS Angiotensin, Thirst, and Sodium Appetite Physiol Rev, July 1, 1998; 78(3): 583 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. S. Summerlee, D. J. Hornsby, and D. G. Ramsey The Dipsogenic Effects of Rat Relaxin: The Effect of Photoperiod and the Potential Role of Relaxin on Drinking in Pregnancy Endocrinology, May 1, 1998; 139(5): 2322 - 2328. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. VilaPorcile and P. Corvol Angiotensinogen, Prorenin, and Renin Are Co-localized in the Secretory Granules of All Glandular Cells of the Rat Anterior Pituitary: An Immunoultrastructural Study J. Histochem. Cytochem., March 1, 1998; 46(3): 301 - 312. [Abstract] [Full Text] |
||||
![]() |
A. J. S. Summerlee, D. G. Ramsey, and R. S. Poterski Neutralization of Relaxin within the Brain Affects the Timing of Birth in Rats Endocrinology, February 1, 1998; 139(2): 479 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Johren, G. L. Sanvitto, G. Egidy, and J. M. Saavedra Angiotensin II AT1A Receptor mRNA Expression Is Induced by Estrogen-Progesterone in Dopaminergic Neurons of the Female Rat Arcuate Nucleus J. Neurosci., November 1, 1997; 17(21): 8283 - 8292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rauch, H. A. Schmid, J. deVente, and E. Simon Electrophysiological and Immunocytochemical Evidence for a cGMP-Mediated Inhibition of Subfornical Organ Neurons by Nitric Oxide J. Neurosci., January 1, 1997; 17(1): 363 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, D. Lu, K. Yu, and M. K. Raizada Regulation of Neuromodulatory Actions of Angiotensin II in the Brain Neurons by the Ras-Dependent Mitogen-Activated Protein Kinase Pathway J. Neurosci., July 1, 1996; 16(13): 4047 - 4058. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Goodfriend, M. E. Elliott, and K. J. Catt Angiotensin Receptors and Their Antagonists N. Engl. J. Med., June 20, 1996; 334(25): 1649 - 1655. [Full Text] [PDF] |
||||
![]() |
H. Yang, D. Lu, and M. K. Raizada Lack of Cross Talk Between {alpha}1-Adrenergic and Angiotensin Type 1 Receptors in Neurons of Spontaneously Hypertensive Rat Brain Hypertension, June 1, 1996; 27(6): 1277 - 1283. [Abstract] [Full Text] |
||||
![]() |
D. J. Campbell, A.-M. Duncan, A. Kladis, and S. B. Harrap Angiotensin Peptides in Spontaneously Hypertensive and Normotensive Donryu Rats Hypertension, May 1, 1995; 25(5): 928 - 934. [Abstract] [Full Text] |
||||
![]() |
M. Salzet, P. Bulet, C. Wattez, M. Verger-Bocquet, and J. Malecha Structural Characterization of a Diuretic Peptide from the Central Nervous System of the Leech Erpobdella octoculata J. Biol. Chem., January 27, 1995; 270(4): 1575 - 1582. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |